{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T19:13:31Z","timestamp":1768677211633,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/s10147-008-0836-5","type":"journal-article","created":{"date-parts":[[2008,12,18]],"date-time":"2008-12-18T14:10:20Z","timestamp":1229609420000},"page":"536-540","source":"Crossref","is-referenced-by-count":11,"title":["Pilot study of intraperitoneal administration of paclitaxel and oral S-1 for patients with peritoneal metastasis due to advanced gastric cancer"],"prefix":"10.1007","volume":"13","author":[{"given":"Shigeyuki","family":"Tamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Miki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Miyake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mio","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rei","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Nakahira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keishi","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Takatsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,12,18]]},"reference":[{"key":"836_CR1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/BF01658939","volume":"17","author":"Y. Yonemura","year":"1993","unstructured":"Yonemura Y, Sawa T, Kinoshita K, et al. (1993) Neoadjuvant chemotherapy for high-grade advanced gastric cancer. World J Surg 17:256\u2013262","journal-title":"World J Surg"},{"key":"836_CR2","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/sj.bjc.6603497","volume":"95","author":"E. Mochiki","year":"2006","unstructured":"Mochiki E, Ohno T, Kamiyama Y, et al. (2006) Phase I\/II study of S-1 combined with paclitaxel in patients with unresectable and\/or recurrent advanced gastric cancer. Br J Cancer 95:1642\u20131647","journal-title":"Br J Cancer"},{"key":"836_CR3","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1158\/1078-0432.CCR-05-2425","volume":"12","author":"K. Yoshida","year":"2006","unstructured":"Yoshida K, Ninomiya M, Takakura N, et al. (2006) Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer. Clin Cancer Res 12:3402\u20133407","journal-title":"Clin Cancer Res"},{"key":"836_CR4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000012086","volume":"58","author":"P.H. Sugerbaker","year":"2000","unstructured":"Sugerbaker PH, Yonemura Y (2000) Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure. Oncology 58:96\u2013107","journal-title":"Oncology"},{"key":"836_CR5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000227206","volume":"50","author":"S. Fujimoto","year":"1993","unstructured":"Fujimoto S, Takahashi M, Kobayashi K, et al. (1993) Relation between clinical and histologic outcome of intraperitoneal hyperthermic perfusion for patients with gastric cancer and peritoneal metastasis. Oncology 50:338\u2013343","journal-title":"Oncology"},{"key":"836_CR6","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/bjs.4695","volume":"92","author":"Y. Yonemura","year":"2005","unstructured":"Yonemura Y, Kawamura T, Bandou S, et al (2005) Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 92:370\u2013375","journal-title":"Br J Surg"},{"key":"836_CR7","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.1992.10.9.1485","volume":"10","author":"M. Markman","year":"1992","unstructured":"Markman M, Rowinsky E, Harkes T, et al. (1992) Phase I trial of intraperitoneal Taxol: a Gynecoloic Oncology Group Study. J Clin Oncol 10:1485\u20131491","journal-title":"J Clin Oncol"},{"key":"836_CR8","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0959-8049(98)00211-1","volume":"34","author":"Y. Sakata","year":"1998","unstructured":"Sakata Y, Ohtsu A, Horikoshi N, et al. (1998) Late phase II study on novel oral fluoropyrimidine anticancer drug S-1 (I M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients. Eur J Cancer 34:1715\u20131720","journal-title":"Eur J Cancer"},{"key":"836_CR9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000012099","volume":"58","author":"W. Koizumi","year":"2000","unstructured":"Koizumi W, Kurihara M, Nakano S, et al. (2000) Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. Oncology 58:191\u2013197","journal-title":"Oncology"},{"key":"836_CR10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000067774","volume":"64","author":"T. Mori","year":"2003","unstructured":"Mori T, Fujiwara Y, Yano M, et al. (2003) Prevention of peritoneal metastasis of human gastric cancer cells in nude mice by S-1, a novel oral derivative of 5-fluorouracil. Oncology 64:176\u2013182","journal-title":"Oncology"},{"key":"836_CR11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/PL00011681","volume":"1","author":"Japanese Gastric Cancer Association","year":"1998","unstructured":"Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma. 2nd English edition. Gastric Cancer 1:25\u201330","journal-title":"Gastric Cancer"},{"key":"836_CR12","volume-title":"Japanese classification of gastric carcinoma","author":"Japanese Research Society for Gastric Cancer","year":"1995","unstructured":"Japanese Research Society for Gastric Cancer (1995) Japanese classification of gastric carcinoma. 1st English edn. Kanehara, Tokyo","edition":"1"},{"key":"836_CR13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s101200050015","volume":"2","author":"W. Koizumi","year":"1999","unstructured":"Koizumi W, Kurihara M, Tanabe S, et al. (1999) Advantage of Japanese response criteria for estimating the survival of patients with primary gastric cancer. Gastric Cancer 2:14\u201319","journal-title":"Gastric Cancer"},{"key":"836_CR14","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/(SICI)1097-0142(19980615)82:12<2307::AID-CNCR2>3.0.CO;2-P","volume":"82","author":"Y. Kakeji","year":"1998","unstructured":"Kakeji Y, Maehara Y, Tomoda M, et al. (1998) Long term survival of patients with stage IV gastric cancer. Cancer 82:2307\u20132311","journal-title":"Cancer"},{"key":"836_CR15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0140-6736(92)90792-2","volume":"339","author":"A. Kashiwara","year":"1992","unstructured":"Kashiwara A, Takahashi T, Kojima O, et al. (1992) Prophylaxis with carbon-absorbed mitomycin C against peritoneal recurrence of gastric cancer. Lancet 339:629\u2013631","journal-title":"Lancet"},{"key":"836_CR16","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ejso.2006.03.007","volume":"32","author":"Y. Yonemura","year":"2006","unstructured":"Yonemura Y, Bandou E, Sawa T, et al. (2006) Neoadjuvant treatment of gastric cancer with peritoneal dissemination. Eur J Surg Oncol 32:661\u2013665","journal-title":"Eur J Surg Oncol"},{"key":"836_CR17","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1200\/JCO.1995.13.12.2961","volume":"13","author":"P. Francis","year":"1995","unstructured":"Francis P, Rowinsky E, Schneider J, et al. (1995) Phase 1 feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot study. J Clin Oncol 13:2961\u20132967","journal-title":"J Clin Oncol"},{"key":"836_CR18","first-page":"1485","volume":"16","author":"M. Markman","year":"1998","unstructured":"Markman M, Brady MF, Spirtos NM, et al. (1998) Phase II trial of intraperitoneal Taxol in carcinoma of the ovary, tube, and peritoneum: a Gynecologic Oncology Group Study. J Clin Oncol 16:1485\u20131491","journal-title":"J Clin Oncol"},{"key":"836_CR19","first-page":"3380","volume":"49","author":"G. Los","year":"1989","unstructured":"Los G, Mutsaers PHA, van der Vijgh WJF, et al. (1989) Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy. Cancer Res 49:3380\u20133384","journal-title":"Cancer Res"},{"key":"836_CR20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/bjc.1994.45","volume":"68","author":"G. Los","year":"1994","unstructured":"Los G, van Vugt MJH, Pinedo HM, et al. (1994) Response of peritoneal solid tumors after intraperitoneal chemo-hyperthermia treatment with cisplatin and carboplatin. Br J Cancer 68:235\u2013241","journal-title":"Br J Cancer"},{"key":"836_CR21","first-page":"2164","volume":"29","author":"S. Fushida","year":"2002","unstructured":"Fushida S, Furui N, Kinami S, et al. (2002) Pharmacologic study of intraperitoneal paclitaxel in gastric cancer patients with peritoneal dissemination (in Japanese). Gan To Kagaku Ryoho (Jpn J Cancer Chemother) 29:2164\u20132167","journal-title":"Gan To Kagaku Ryoho (Jpn J Cancer Chemother)"},{"key":"836_CR22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canlet.2004.03.018","volume":"210","author":"Y. Yonemura","year":"2004","unstructured":"Yonemura Y, Endou Y, Bando E, et al. (2004) Effect of intraperitoneal administration of docetaxel on peritoneal dissemination of gastric cancer. Cancer Lett 210:189\u2013196","journal-title":"Cancer Lett"},{"key":"836_CR23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10120-007-0431-x","volume":"10","author":"S. Tamura","year":"2007","unstructured":"Tamura S, Miki H, Nakata K, et al. (2007) Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer. Gastric Cancer 10:251\u2013255","journal-title":"Gastric Cancer"},{"key":"836_CR24","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00001813-199607000-00010","volume":"7","author":"T. Shirasaka","year":"1996","unstructured":"Shirasaka T, Shimamoto Y, Ohshimo H, et al. (1996) Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators. Anticancer Drugs 7:548\u2013557","journal-title":"Anticancer Drugs"},{"key":"836_CR25","first-page":"811","volume":"9","author":"H. Osugi","year":"2002","unstructured":"Osugi H, Takada N, Takemura M, et al. (2002) Oral fluoropyrimidine anticancer drug TS-1 for gastric cancer patients with peritoneal dissemination. Oncol Rep 9:811\u2013815","journal-title":"Oncol Rep"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-008-0836-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-008-0836-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-008-0836-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:24:49Z","timestamp":1559147089000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-008-0836-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["836"],"URL":"https:\/\/doi.org\/10.1007\/s10147-008-0836-5","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}